Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

India approved COVID-19 vaccine called Covaxin, developed by the Indian Council of Medical Research and Bharat Biotech Ltd. The primary objective of the study was to estimate the effectiveness of Covaxin in preventing breakthrough SARS-CoV-2 infection in healthcare workers (HCWs). A test-negative ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Behera, Priyamadhaba, Singh, Arvind Kumar, Subba, Sonu Hangma, Mc, Arjun, Sahu, Dinesh Prasad, Chandanshive, Pradnya Dilip, Pradhan, Somen Kumar, Parida, Swayam Pragyan, Mishra, Abhisek, Patro, Binod Kumar, Batmanabane, Gitanjali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009960/
https://www.ncbi.nlm.nih.gov/pubmed/35321625
http://dx.doi.org/10.1080/21645515.2022.2034456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009960/
https://www.ncbi.nlm.nih.gov/pubmed/35321625
http://dx.doi.org/10.1080/21645515.2022.2034456

Ejemplares similares